1 Reksa Dana Terbaik dengan H2K2 / XTL Biopharmaceuticals Ltd. - Depositary Receipt (Common Stock) (DB)

XTL Biopharmaceuticals Ltd. - Depositary Receipt (Common Stock)
DE ˙ DB
€ 1.02 ↑0.06 (5.70%)
2025-09-05
BAHAGING PRESYO
1 Reksa Dana Terbaik dengan DE:H2K2 / XTL Biopharmaceuticals Ltd. - Depositary Receipt (Common Stock)

Halaman ini menampilkan semua reksa dana yang telah melaporkan posisi di DE:H2K2 / XTL Biopharmaceuticals Ltd. - Depositary Receipt (Common Stock). Baris berwarna hijau menunjukkan posisi baru. Klik tautan ikon untuk melihat riwayat transaksi selengkapnya.

Tingkatkan ke versi premium untuk membuka data premium dan ekspor ke Excel. .

Tanggal File Sumber Investor Ketik Presyo ng Avg
(Silangan)
Saham Δ Saham
(%)
Dilaporkan
Nilai
($1000)
Nilai Δ
(%)
Alokasi Port
(%)
2025-07-24 NP FNCMX - Fidelity Nasdaq Composite Index Fund This fund is a listed as child fund of Fmr Llc and if that institution has disclosed ownership in this security, then these positions will not be double counted when calculating total shares and total value 8,903 0.00 11 0.00
Other Listings
US:XTLB US$ 1.12
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista